home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

An Easy to Implement Integrated Risk Management Approach Compliant with ISO 14971

 
  December 30, 2010  
     
 


ComplianceOnline, Online Event
2011-01-10


NOTE: Use This Promocode ( 117660 ) To Get 10% Discount. 

Why Should You Attend:

ISO 14971 Medical devices - Application of risk management to medical devices is a voluntary standard that medical device manufacturers must incorporate into their design and development process in order to ensure medical devices designed are safe and effective. The FDA now also recognizes ISO14971, and can audit to it if manufacturer's claim they conform to it. Although ISO 14971 has been in place since 1998, many companies still find it difficult to properly interpret the requirements of the standards and having a risk management process which is not helpful in designing robust, safe medical devices.

This webinar will cover all major elements of ISO 14971 and present a methodology for integrating the requirements of this standard into the product development process to ensure that the requirements of the standard are met, and the medical device is designed to be safe and effective. The webinar will specify how risk management activities are incorporated in all phases of development, and what supporting documentation needs to be gathered in order to ensure that decisions made based on what is learned as part of the risk management process are adequately justified and documented.

Areas Covered in the Seminar:

  • How are risk management activities integrated throughout the development process.
  • The roles that Hazard Analysis, FTA, FMEA, HAZOP and PFMEA play in an Integrated Risk Management Process.
  • How to control and verify risk mitigations.
  • How to perform a Risk Benefit Analysis on ALARP and INTOLARABLE Hazards.
  • The importance of maintaing Risk Management documents in the Post Production era.
  • What information to include in the Risk Management Plan and Report for better auditability.
 
 
Organized by: ComplianceOnline
Invited Speakers: Mercedes Massana, is the founder and CEO of MDM Engineering Consultants, a consulting firm that provides engineering and quality consulting services in the medical device, biotechnology, and pharmaceutical industries. Mercedes has over twenty-five years of experience in the Medical Device industry. Extensive experience in developing processes within the constraints of FDA/lSO Quality Systems. She has been responsible for establishing processes and leading groups of engineering in the following disciplines: Risk Management, Requirements Management, Verification and Validation, Process Improvements, Project Management, Software Systems Validation, Process Validation. Mercedes is an ASQ certified Biomedical Auditor (CBA), Software Quality Engineer (CSQE), Quality Manager (CQMa) and Quality Auditor (CQA). Mercedes is well versed in FDA and ISO regulations.
 
Deadline for Abstracts: 2011-01-10
 
Registration:

Attend Live Online Training 

$249.00 One Dial-in One Attendee

$999.00 Group–Max. 10 Attendees 

 

E-mail: admin@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.